IREN
IREN Limited
There isn't enough reported data to score IREN yet.
NKSH
National Bankshares, Inc.
NKSH's fundamentals are strong: its operating margin rose 12 points to 42% and revenue grew 19%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect strong earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
NKSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
NKSH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like NKSH.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
NKSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $32.39 | -18% |
| Forward | 10x | $39.59 | — |
| Current | 12x | $39.59 | — |
| Fair | 13x | $42.43 | +7.2% |
| Expensive | 17x | $56.42 | +42% |
Historical ranges are pointers, not guarantees.
NKSH's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
NKSH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
NKSH has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
NKSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.85 | +15% |
| Q3 2026 | $3.36 | +63% |
| Q2 2026 | $3.19 | +78% |
| Q1 2026 | $2.76 | +100% |
| Q4 2025 | $2.49 | +101% |
| Q3 2025 | $2.06 | +42% |
| Q2 2025 | $1.79 | +15% |
| Q1 2025 | $1.38 | -39% |
| Q4 2024 | $1.24 | -53% |
NKSH has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
NKSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.4M | +16% |
| Q2 2026 | $15.7M | +18% |
| Q1 2026 | $15.3M | +19% |
| Q4 2025 | $15.3M | +25% |
| Q3 2025 | $14.2M | +21% |
| Q2 2025 | $13.3M | +21% |
| Q1 2025 | $12.8M | +23% |
| Q4 2024 | $12.2M | +14% |
NKSH's revenue has grown year over year for nine quarters in a row: $16M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +3.4 points |
| Q2 2026 | 39% | +19 points |
| Q1 2026 | 40% | +9.1 points |
| Q4 2025 | 47% | +17 points |
| Q3 2025 | 38% | +10 points |
| Q2 2025 | 20% | +24 points |
| Q1 2025 | 30% | +4.7 points |
| Q4 2024 | 30% | -17 points |
NKSH has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
NKSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.1M | +33% |
| Q2 2026 | $3.3M | +118% |
| Q1 2026 | $3.1M | +92% |
| Q4 2025 | $6.7M | +50% |
| Q2 2025 | $1.5M | +$4.5M |
| Q1 2025 | $1.6M | -58% |
| Q2 2024 | -$2.9M | -173% |
| Q1 2024 | $3.8M | -11% |
NKSH has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
NKSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.3K shares |
| 1 year | +0.1% | +5.1K shares |
| 3 years | +8.1% | +479K shares |
| 5 years | +3.7% | +226K shares |
| Available history | -3.2% | -212K shares |
NKSH has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $2.6M |
| Q3 2022 | $796,000 |
| Q2 2022 | $1.4M |
| Q1 2022 | $1.5M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
NKSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.7x | Net Cash |
| Q4 2025 | -2.9x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -6.3x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2024 | -10.5x | Net Cash |
NKSH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like NKSH.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
NKSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 18.9 | Oversold |
NKSH's weekly RSI is 50 (neutral) and its Stochastic is 19 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
NKSH PE vs Financial Services Sector
| Metric | NKSH | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9.5% below |
| PE % | 42 | 63 | 21 pts below |
NKSH is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
NKSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $41.3 | 4.2% below |
| 20 week MA | $40.6 | 2.4% below |
| 50 week MA | $37.7 | 5% above |
| 100 week MA | $32.9 | 20% above |
| 200 week MA | $31.8 | 25% above |
NKSH has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
NKSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.1 | $31.7 | -31% |
| 2021 | $31.7 | $35.6 | +12% |
| 2022 | $35.6 | $39.8 | +12% |
| 2023 | $39.8 | $32.4 | -19% |
| 2024 | $32.4 | $28.4 | -12% |
| 2025 | $28.4 | $33.9 | +19% |
| 2026 YTD | $33.9 | $39.6 | +17% |
NKSH has the edge over IREN on returns for 2026, with the stronger performance.